A 54-year-old male architect is evaluated for a first episode of pervasive sadness, early morning awakening, and severe anhedonia. Over the subsequent 14 months, his clinical course is characterized by progressive treatment resistance, ultimately culminating in an inpatient psychiatric admission for life-threatening symptoms. According to evidence-based stepped-care guidelines for Major Depressive Disorder, arrange the following management steps in the most appropriate chronological order, corresponding to his clinical evolution from initial presentation to severe, refractory illness.
- 1Screen for a history of hypomanic or manic episodes and obtain baseline laboratory studies including a TSH level.
- 2Initiate monotherapy with a selective serotonin reuptake inhibitor (SSRI) and titrate to a therapeutic dose.
- 3Cross-taper to a serotonin-norepinephrine reuptake inhibitor (SNRI) after the patient exhibits zero clinical response and intolerable sexual side effects on the initial agent.
- 4Prescribe adjunctive aripiprazole after the optimized SNRI regimen yields only a partial reduction in depressive symptoms with good tolerability.
- 5Discontinue outpatient pharmacotherapy and initiate acute electroconvulsive therapy (ECT) upon the emergence of mood-congruent delusions and absolute food refusal.
Cevap
The correct chronological sequence of stepped-care management is: 1) Screen for bipolar disorder and medical mimics, 2) Initiate SSRI monotherapy, 3) Switch to an SNRI due to non-response and side effects, 4) Augment with aripiprazole for partial response, and 5) Initiate ECT for the development of psychotic features and food refusal.
The management of Major Depressive Disorder follows a highly evidence-based stepped-care algorithm. First, all patients must be screened for bipolar disorder and medical mimics (e.g., hypothyroidism) before initiating treatment to avoid precipitating mania. Second, an SSRI is the appropriate first-line pharmacotherapy. Third, if a patient has a complete lack of response and experiences intolerable side effects, the correct algorithmic step is to switch to a different class of antidepressant (e.g., an SNRI). Fourth, if a subsequent trial yields a partial response and is well-tolerated, the algorithm shifts to augmentation (e.g., adding an atypical antipsychotic like aripiprazole or a mood stabilizer like lithium) to build upon the partial gains. Finally, if the patient clinically deteriorates and develops life-threatening features, such as psychosis, catatonia, or refusal to eat, all standard outpatient pharmacotherapy algorithms are superseded by the need for immediate Electroconvulsive Therapy (ECT).
Adım Adım Çözüm
Anahtar Kavram
Stepped-care pharmacotherapy algorithm for Major Depressive Disorder (MDD), specifically distinguishing indications for switching versus augmentation, and identifying absolute indications for ECT.